We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Mechanistic Study of ISIS ISIS-APOCIIIRX in Type 2 Diabetes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01647308
Recruitment Status : Terminated (The study was terminated for business planning purposes. Assessments of APOCIIIRx in this population will be explored in a larger efficacy study)
First Posted : July 23, 2012
Last Update Posted : July 15, 2014
Information provided by (Responsible Party):
Ionis Pharmaceuticals, Inc.